- Home
- ATRC vs REAL Comparison
ATRC vs REAL Comparison
Compare ATRC & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- REAL
- Stock Information
- Founded
- ATRC 2000
- REAL 2011
- Country
- ATRC United States
- REAL United States
- Employees
- ATRC N/A
- REAL N/A
- Industry
- ATRC Medical/Dental Instruments
- REAL Other Specialty Stores
- Sector
- ATRC Health Care
- REAL Consumer Discretionary
- Exchange
- ATRC Nasdaq
- REAL Nasdaq
- Market Cap
- ATRC 1.1B
- REAL 1.2B
- IPO Year
- ATRC 2005
- REAL 2019
- Fundamental
- Price
- ATRC $40.58
- REAL $9.47
- Analyst Decision
- ATRC Strong Buy
- REAL Buy
- Analyst Count
- ATRC 9
- REAL 6
- Target Price
- ATRC $43.00
- REAL $7.04
- AVG Volume (30 Days)
- ATRC 538.9K
- REAL 3.3M
- Earning Date
- ATRC 02-12-2025
- REAL 02-27-2025
- Dividend Yield
- ATRC N/A
- REAL N/A
- EPS Growth
- ATRC N/A
- REAL N/A
- EPS
- ATRC N/A
- REAL N/A
- Revenue
- ATRC $447,573,000.00
- REAL $579,862,000.00
- Revenue This Year
- ATRC $17.75
- REAL $11.26
- Revenue Next Year
- ATRC $13.44
- REAL $8.81
- P/E Ratio
- ATRC N/A
- REAL N/A
- Revenue Growth
- ATRC 17.56
- REAL 2.52
- 52 Week Low
- ATRC $18.94
- REAL $1.52
- 52 Week High
- ATRC $41.05
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- ATRC 74.37
- REAL 55.77
- Support Level
- ATRC $38.99
- REAL $9.21
- Resistance Level
- ATRC $41.05
- REAL $10.00
- Average True Range (ATR)
- ATRC 1.92
- REAL 0.59
- MACD
- ATRC 0.88
- REAL -0.13
- Stochastic Oscillator
- ATRC 95.59
- REAL 66.81
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.